CEACAM8(Antigen gene) Market - Global Outlook and Forecast 2022-2028

January 2022 | 67 pages | ID: C20A47A5CC83EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of CEACAM8(Antigen gene) in Global, including the following market information:

Global CEACAM8(Antigen gene) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global CEACAM8(Antigen gene) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Above 95% Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of CEACAM8(Antigen gene) include Thermo Fisher Scientific, R&D Systems, Lifespan Biosciences, Bio-Rad, Abbexa Ltd, Boster Bio, Atlas Antibodies, Biobyt and Novus Biologicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CEACAM8(Antigen gene) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CEACAM8(Antigen gene) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global CEACAM8(Antigen gene) Market Segment Percentages, by Type, 2021 (%)

• Above 95%
• Above 99%
• Others

Global CEACAM8(Antigen gene) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global CEACAM8(Antigen gene) Market Segment Percentages, by Application, 2021 (%)

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Global CEACAM8(Antigen gene) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global CEACAM8(Antigen gene) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CEACAM8(Antigen gene) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies CEACAM8(Antigen gene) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• R&D Systems
• Lifespan Biosciences
• Bio-Rad
• Abbexa Ltd
• Boster Bio
• Atlas Antibodies
• Biobyt
• Novus Biologicals
• Aviva Systems Biology
• ProSci
• BioLegend

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 CEACAM8(Antigen gene) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global CEACAM8(Antigen gene) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CEACAM8(ANTIGEN GENE) OVERALL MARKET SIZE

2.1 Global CEACAM8(Antigen gene) Market Size: 2021 VS 2028
2.2 Global CEACAM8(Antigen gene) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top CEACAM8(Antigen gene) Players in Global Market
3.2 Top Global CEACAM8(Antigen gene) Companies Ranked by Revenue
3.3 Global CEACAM8(Antigen gene) Revenue by Companies
3.4 Top 3 and Top 5 CEACAM8(Antigen gene) Companies in Global Market, by Revenue in 2021
3.5 Global Companies CEACAM8(Antigen gene) Product Type
3.6 Tier 1, Tier 2 and Tier 3 CEACAM8(Antigen gene) Players in Global Market
  3.6.1 List of Global Tier 1 CEACAM8(Antigen gene) Companies
  3.6.2 List of Global Tier 2 and Tier 3 CEACAM8(Antigen gene) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global CEACAM8(Antigen gene) Market Size Markets, 2021 & 2028
  4.1.2 Above 95%
  4.1.3 Above 99%
  4.1.4 Others
4.2 By Type - Global CEACAM8(Antigen gene) Revenue & Forecasts
  4.2.1 By Type - Global CEACAM8(Antigen gene) Revenue, 2017-2022
  4.2.2 By Type - Global CEACAM8(Antigen gene) Revenue, 2023-2028
  4.2.3 By Type - Global CEACAM8(Antigen gene) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global CEACAM8(Antigen gene) Market Size, 2021 & 2028
  5.1.2 Biopharmaceutical Companies
  5.1.3 Hospitals
  5.1.4 Bioscience Research Institutions
  5.1.5 Others
5.2 By Application - Global CEACAM8(Antigen gene) Revenue & Forecasts
  5.2.1 By Application - Global CEACAM8(Antigen gene) Revenue, 2017-2022
  5.2.2 By Application - Global CEACAM8(Antigen gene) Revenue, 2023-2028
  5.2.3 By Application - Global CEACAM8(Antigen gene) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global CEACAM8(Antigen gene) Market Size, 2021 & 2028
6.2 By Region - Global CEACAM8(Antigen gene) Revenue & Forecasts
  6.2.1 By Region - Global CEACAM8(Antigen gene) Revenue, 2017-2022
  6.2.2 By Region - Global CEACAM8(Antigen gene) Revenue, 2023-2028
  6.2.3 By Region - Global CEACAM8(Antigen gene) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America CEACAM8(Antigen gene) Revenue, 2017-2028
  6.3.2 US CEACAM8(Antigen gene) Market Size, 2017-2028
  6.3.3 Canada CEACAM8(Antigen gene) Market Size, 2017-2028
  6.3.4 Mexico CEACAM8(Antigen gene) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe CEACAM8(Antigen gene) Revenue, 2017-2028
  6.4.2 Germany CEACAM8(Antigen gene) Market Size, 2017-2028
  6.4.3 France CEACAM8(Antigen gene) Market Size, 2017-2028
  6.4.4 U.K. CEACAM8(Antigen gene) Market Size, 2017-2028
  6.4.5 Italy CEACAM8(Antigen gene) Market Size, 2017-2028
  6.4.6 Russia CEACAM8(Antigen gene) Market Size, 2017-2028
  6.4.7 Nordic Countries CEACAM8(Antigen gene) Market Size, 2017-2028
  6.4.8 Benelux CEACAM8(Antigen gene) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia CEACAM8(Antigen gene) Revenue, 2017-2028
  6.5.2 China CEACAM8(Antigen gene) Market Size, 2017-2028
  6.5.3 Japan CEACAM8(Antigen gene) Market Size, 2017-2028
  6.5.4 South Korea CEACAM8(Antigen gene) Market Size, 2017-2028
  6.5.5 Southeast Asia CEACAM8(Antigen gene) Market Size, 2017-2028
  6.5.6 India CEACAM8(Antigen gene) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America CEACAM8(Antigen gene) Revenue, 2017-2028
  6.6.2 Brazil CEACAM8(Antigen gene) Market Size, 2017-2028
  6.6.3 Argentina CEACAM8(Antigen gene) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa CEACAM8(Antigen gene) Revenue, 2017-2028
  6.7.2 Turkey CEACAM8(Antigen gene) Market Size, 2017-2028
  6.7.3 Israel CEACAM8(Antigen gene) Market Size, 2017-2028
  6.7.4 Saudi Arabia CEACAM8(Antigen gene) Market Size, 2017-2028
  6.7.5 UAE CEACAM8(Antigen gene) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific CEACAM8(Antigen gene) Major Product Offerings
  7.1.4 Thermo Fisher Scientific CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 R&D Systems
  7.2.1 R&D Systems Corporate Summary
  7.2.2 R&D Systems Business Overview
  7.2.3 R&D Systems CEACAM8(Antigen gene) Major Product Offerings
  7.2.4 R&D Systems CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.2.5 R&D Systems Key News
7.3 Lifespan Biosciences
  7.3.1 Lifespan Biosciences Corporate Summary
  7.3.2 Lifespan Biosciences Business Overview
  7.3.3 Lifespan Biosciences CEACAM8(Antigen gene) Major Product Offerings
  7.3.4 Lifespan Biosciences CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.3.5 Lifespan Biosciences Key News
7.4 Bio-Rad
  7.4.1 Bio-Rad Corporate Summary
  7.4.2 Bio-Rad Business Overview
  7.4.3 Bio-Rad CEACAM8(Antigen gene) Major Product Offerings
  7.4.4 Bio-Rad CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.4.5 Bio-Rad Key News
7.5 Abbexa Ltd
  7.5.1 Abbexa Ltd Corporate Summary
  7.5.2 Abbexa Ltd Business Overview
  7.5.3 Abbexa Ltd CEACAM8(Antigen gene) Major Product Offerings
  7.5.4 Abbexa Ltd CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.5.5 Abbexa Ltd Key News
7.6 Boster Bio
  7.6.1 Boster Bio Corporate Summary
  7.6.2 Boster Bio Business Overview
  7.6.3 Boster Bio CEACAM8(Antigen gene) Major Product Offerings
  7.6.4 Boster Bio CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.6.5 Boster Bio Key News
7.7 Atlas Antibodies
  7.7.1 Atlas Antibodies Corporate Summary
  7.7.2 Atlas Antibodies Business Overview
  7.7.3 Atlas Antibodies CEACAM8(Antigen gene) Major Product Offerings
  7.7.4 Atlas Antibodies CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.7.5 Atlas Antibodies Key News
7.8 Biobyt
  7.8.1 Biobyt Corporate Summary
  7.8.2 Biobyt Business Overview
  7.8.3 Biobyt CEACAM8(Antigen gene) Major Product Offerings
  7.8.4 Biobyt CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.8.5 Biobyt Key News
7.9 Novus Biologicals
  7.9.1 Novus Biologicals Corporate Summary
  7.9.2 Novus Biologicals Business Overview
  7.9.3 Novus Biologicals CEACAM8(Antigen gene) Major Product Offerings
  7.9.4 Novus Biologicals CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.9.5 Novus Biologicals Key News
7.10 Aviva Systems Biology
  7.10.1 Aviva Systems Biology Corporate Summary
  7.10.2 Aviva Systems Biology Business Overview
  7.10.3 Aviva Systems Biology CEACAM8(Antigen gene) Major Product Offerings
  7.10.4 Aviva Systems Biology CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.10.5 Aviva Systems Biology Key News
7.11 ProSci
  7.11.1 ProSci Corporate Summary
  7.11.2 ProSci Business Overview
  7.11.3 ProSci CEACAM8(Antigen gene) Major Product Offerings
  7.11.4 ProSci CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.11.5 ProSci Key News
7.12 BioLegend
  7.12.1 BioLegend Corporate Summary
  7.12.2 BioLegend Business Overview
  7.12.3 BioLegend CEACAM8(Antigen gene) Major Product Offerings
  7.12.4 BioLegend CEACAM8(Antigen gene) Revenue in Global Market (2017-2022)
  7.12.5 BioLegend Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. CEACAM8(Antigen gene) Market Opportunities & Trends in Global Market
Table 2. CEACAM8(Antigen gene) Market Drivers in Global Market
Table 3. CEACAM8(Antigen gene) Market Restraints in Global Market
Table 4. Key Players of CEACAM8(Antigen gene) in Global Market
Table 5. Top CEACAM8(Antigen gene) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CEACAM8(Antigen gene) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CEACAM8(Antigen gene) Revenue Share by Companies, 2017-2022
Table 8. Global Companies CEACAM8(Antigen gene) Product Type
Table 9. List of Global Tier 1 CEACAM8(Antigen gene) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CEACAM8(Antigen gene) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CEACAM8(Antigen gene) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CEACAM8(Antigen gene) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CEACAM8(Antigen gene) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CEACAM8(Antigen gene) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CEACAM8(Antigen gene) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CEACAM8(Antigen gene) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CEACAM8(Antigen gene) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CEACAM8(Antigen gene) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CEACAM8(Antigen gene) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CEACAM8(Antigen gene) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CEACAM8(Antigen gene) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CEACAM8(Antigen gene) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CEACAM8(Antigen gene) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CEACAM8(Antigen gene) Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific CEACAM8(Antigen gene) Product Offerings
Table 32. Thermo Fisher Scientific CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 33. R&D Systems Corporate Summary
Table 34. R&D Systems CEACAM8(Antigen gene) Product Offerings
Table 35. R&D Systems CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 36. Lifespan Biosciences Corporate Summary
Table 37. Lifespan Biosciences CEACAM8(Antigen gene) Product Offerings
Table 38. Lifespan Biosciences CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 39. Bio-Rad Corporate Summary
Table 40. Bio-Rad CEACAM8(Antigen gene) Product Offerings
Table 41. Bio-Rad CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 42. Abbexa Ltd Corporate Summary
Table 43. Abbexa Ltd CEACAM8(Antigen gene) Product Offerings
Table 44. Abbexa Ltd CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 45. Boster Bio Corporate Summary
Table 46. Boster Bio CEACAM8(Antigen gene) Product Offerings
Table 47. Boster Bio CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 48. Atlas Antibodies Corporate Summary
Table 49. Atlas Antibodies CEACAM8(Antigen gene) Product Offerings
Table 50. Atlas Antibodies CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 51. Biobyt Corporate Summary
Table 52. Biobyt CEACAM8(Antigen gene) Product Offerings
Table 53. Biobyt CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 54. Novus Biologicals Corporate Summary
Table 55. Novus Biologicals CEACAM8(Antigen gene) Product Offerings
Table 56. Novus Biologicals CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 57. Aviva Systems Biology Corporate Summary
Table 58. Aviva Systems Biology CEACAM8(Antigen gene) Product Offerings
Table 59. Aviva Systems Biology CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 60. ProSci Corporate Summary
Table 61. ProSci CEACAM8(Antigen gene) Product Offerings
Table 62. ProSci CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)
Table 63. BioLegend Corporate Summary
Table 64. BioLegend CEACAM8(Antigen gene) Product Offerings
Table 65. BioLegend CEACAM8(Antigen gene) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. CEACAM8(Antigen gene) Segment by Type in 2021
Figure 2. CEACAM8(Antigen gene) Segment by Application in 2021
Figure 3. Global CEACAM8(Antigen gene) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global CEACAM8(Antigen gene) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CEACAM8(Antigen gene) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CEACAM8(Antigen gene) Revenue in 2021
Figure 8. By Type - Global CEACAM8(Antigen gene) Revenue Market Share, 2017-2028
Figure 9. By Application - Global CEACAM8(Antigen gene) Revenue Market Share, 2017-2028
Figure 10. By Region - Global CEACAM8(Antigen gene) Revenue Market Share, 2017-2028
Figure 11. By Country - North America CEACAM8(Antigen gene) Revenue Market Share, 2017-2028
Figure 12. US CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CEACAM8(Antigen gene) Revenue Market Share, 2017-2028
Figure 16. Germany CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 17. France CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CEACAM8(Antigen gene) Revenue Market Share, 2017-2028
Figure 24. China CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 28. India CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CEACAM8(Antigen gene) Revenue Market Share, 2017-2028
Figure 30. Brazil CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CEACAM8(Antigen gene) Revenue Market Share, 2017-2028
Figure 33. Turkey CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CEACAM8(Antigen gene) Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. R&D Systems CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Lifespan Biosciences CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bio-Rad CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Abbexa Ltd CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Boster Bio CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Atlas Antibodies CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biobyt CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novus Biologicals CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Aviva Systems Biology CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ProSci CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. BioLegend CEACAM8(Antigen gene) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)